We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.small Co.2 Regulatory News (BSC)

Share Price Information for Br.small Co.2 (BSC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 56.50
Bid: 55.50
Ask: 57.50
Change: 0.00 (0.00%)
Spread: 2.00 (3.604%)
Open: 56.50
High: 56.50
Low: 56.50
Prev. Close: 56.50
BSC Live PriceLast checked at -
British Smaller Companies VCT 2 is an Investment Trust

To create a portfolio that blends a mix of businesses operating in established industries with those that offer opportunities in the application and development of innovation.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

7 May 2019 09:53

RNS Number : 2085Y
British Smaller Companies VCT2 Plc
07 May 2019
 

British Smaller Companies VCT2 plc

Interim Management Statement

For the quarter ended 31 March 2019

British Smaller Companies VCT2 plc (the "Company") presents its interim management statement for the quarter ended 31 March 2019. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make progress in the quarter with total return rising to 118.5 pence per ordinary share. This is an increase of 0.1 pence per ordinary share.

At 31 March 2019 net asset value ("NAV") was £59.6 million, a fall of £4.5 million, £4.3 of which arose from the payment of the interim dividend of 5.0 pence per ordinary share on 15 February 2019 (net of the shares issued under the Company's DRIS). There were £0.4 million of share buy backs in the period, also reducing the net assets, and £0.2 million of other, positive movements.

The Company has had a strong start to the year, with investments totalling £1.7 million to date and a successful fundraising, alongside British Smaller Companies VCT plc, which raised net proceeds of £12.7 million in April 2019.

Performance

The movement in Total Shareholder Return in pence per ordinary share is set out in the table below:

Pence per

ordinary share

Cumulative dividends to 31 December 2018

58.5

Net Asset Value at 31 December 2018

59.9

Total Shareholder Return at 31 December 2018

118.4

Net underlying increase in portfolio

0.3

Net income after expenses / share buybacks

(0.2)

Increase in Total Shareholder Return

0.1

Total Shareholder Return at 31 March 2019

118.5

 

31 March 2019

Movement

31 December 2018

Net Assets (£m)

59.6

(4.5)

64.1

NAV per share (PPS)

55.0p

(4.9p)

59.9p

Cumulative dividends paid (PPS)

63.5p

5.0p

58.5p

Total Return (PPS)

118.5p

0.1p

118.4p

Shares in issue

108,459,010

1,440,190

107,018,820

 

The total return at 31 March 2019, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 118.5 pence per ordinary share compared to 118.4 pence per ordinary share at 31 December 2018. Cumulative dividends paid were up 5.0 pence per ordinary share at 63.5 pence per ordinary share (31 December 2018: 58.5 pence per ordinary share).

The unaudited NAV per ordinary share as at 31 March 2019 was 55.0 pence per ordinary share (31 December 2018: 59.9 pence per ordinary share) representing an increase of 0.1 pence per ordinary share from the portfolio offset by the interim dividend of 5.0 pence per share paid on 15 February 2019.

Dividends and shares in issue

As a result of the realisations in December 2018 a special interim dividend, representing the realised gain over the original cost of the investments, of 5.0 pence per ordinary share was paid on 15 February 2019. On the same date 2,248,386 ordinary shares were issued under the Company's DRIS.

On 26 March 2019 the Company purchased 808,196 ordinary shares of 10 pence each at a price of 52.66 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 March 2019 was 108,459,010 (31 December 2018: 100,018,820). In addition, at 31 March 2019 the Company held 6,966,757 ordinary shares in treasury (31 December 2018: 6,158,561).

Subsequent to the quarter end the Company issued 23,205,679 ordinary shares relating to the fundraising following which the Company's issued share capital consists of 131,664,689 ordinary shares of 10 pence each with voting rights and 6,966,757 ordinary shares of 10 pence each held in treasury.

 

Net assets

Net assets at 31 March 2019 comprised the following:

£000

% of net assets

Unquoted investments at fair value

38,887

65.2

Quoted investments at bid price

1,075

1.8

Total investments

39,962

67.0

Cash and cash equivalents

18,569

31.2

Other net current assets

1,069

1.8

Net assets

59,600

100.0

 

The investment portfolio at 31 March 2019 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Matillion Limited

5,489

9.2

ACC Aviation

5,440

9.1

Intelligent Office UK

3,021

5.1

Business Collaborator Limited

2,441

4.1

KeTech Enterprises Limited

2,231

3.8

Deep-Secure Ltd

2,110

3.5

Eikon Holdco Limited

2,095

3.5

Springboard Research Holdings Limited

1,687

2.8

Leengate Valves Limited

1,291

2.2

Frescobol Carioca Limited

1,200

2.0

27,005

45.3

Other investments

12,957

21.7

Total investments

39,962

67.0

 

During the quarter to 31 March 2019 the Company made one new investment of £1.2 million into Frescobol Carioca Limited, the luxury men's resort wear and lifestyle brand. The Company also made follow-on investments totalling £0.5 million into four portfolio companies.

In the quarter to 31 March 2019 the realisation and repayment of investments generated cash proceeds of £0.1 million.

In April 2019 the Company realised its investment in Leengate Valves Limited generating proceeds of £1.3 million and delivering a total return of £2.2 million, a multiple of 2.3x original cost.

Investments made prior to the November 2015 Budget represented 62 per cent of the value of the unquoted portfolio at 31 March 2019 and, following the Leengate disposal, they now represent 61 per cent of the unquoted portfolio.

 

Portfolio Performance

Over the quarter to 31 March 2019 the aggregate unrealised portfolio valuation has increased by £0.3 million.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 March 2019, only three investments represented more than 5 per cent of the Company's NAV, the largest being 9.2 per cent, with the top ten investments representing 45.3 per cent of NAV (31 December 2018 41.0 per cent).

Fundraising

On 27 November 2018 your Company launched a new share offer with British Smaller Companies VCT plc to raise in aggregate up to £30 million, with an over-allotment facility of £5 million. I am delighted that due to strong demand the offer closed on 11 February 2019 raising total gross proceeds of £35 million. The allotment of new ordinary shares took place on 1 April 2019, subsequent to which your Company received net proceeds of £12.5 million. On the same date a further £0.2million was raised by allotting shares outside the Offers.

Board Composition

After 19 years Richard Last will step down from the Board later today at the end of this year's AGM. The Board would like to thank Richard for his significant contribution to the Company, especially its evolution from its merger with British Smaller Technologies Company VCT plc to co-investing alongside British Smaller Companies VCT plc.

Outlook

Despite the turmoil in Westminster smaller businesses continue to grow and innovate. The Company continues to invest, with one new investment in the quarter and a number of follow-on investments to support further growth and facilitate strategic change. There are a number of opportunities at the advanced stages of review and the success of the recent fundraising allows the Company to continue to take advantage of these opportunities as well as providing capacity for follow-on funding which will inevitably be required.

Undoubtedly the work done with HMRC to improve their advance assurance process by the Investment Adviser, as a member of the VCT Association, is helping to speed up the process of investments and further progress in this area remains the target.

The Company's portfolio continues to evolve, with investments since the November 2015 Budget now representing 38 per cent of the portfolio's value and the Board will continue to review its dividend policies as the more mature investments are realised. A number of investments are currently in sale processes and, as with the realisations of Gill Marine, Mangar and GTK in December 2018, the Board would hope to pay special dividends on future realisations.

Your Board remains focussed on maximising long-term Total Shareholder Return.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

7 May 2019

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRFDMGGKRNLGLZG
Date   Source Headline
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20248:04 amRNSDirector/PDMR Shareholding
3rd Apr 20247:57 amRNSIssue of Equity and Close of Offers
26th Mar 202411:10 amRNSTransaction in Own Shares and Total Voting Rights
21st Mar 20247:40 amRNSAppointment of non-executive Director
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNSAnnual Financial Report
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:26 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSDirector/PDMR Shareholding
30th Jan 20249:24 amRNSIssue of Equity
18th Dec 20234:04 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
24th Nov 20237:00 amRNS3rd Quarter Results
3rd Nov 20239:40 amRNSPayment of dividend and issue of equity
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:16 amRNSTransaction in Own Shares
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
13th Sep 20237:00 amRNSHalf-year Report
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
27th Jun 20237:46 amRNSTransaction in Own Shares
26th Jun 202310:57 amRNSDirector/PDMR Shareholding
26th Jun 202310:56 amRNSPayment of Dividend and Issue of Equity
16th Jun 202312:00 pmRNS1st Quarter Results
15th Jun 20233:17 pmRNSResult of Meeting
15th Jun 20233:16 pmRNSResult of AGM
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:25 pmRNSDirector/PDMR Shareholding
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:22 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:40 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
23rd Mar 202311:30 amRNSPublication of Circular
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNSAnnual Financial Report
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:50 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.